Table 4.
[CRP] (b) | [LPS] (b) | [anti-Aa] (b) | [anti-Pg] (b) | ||
---|---|---|---|---|---|
Sample (a) | Pathogen | Coefficient ± SE (c) | Coefficient ± SE (c) | Coefficient ± SE (c) | Coefficient ± SE (c) |
Saliva | Aa | −0.034 ± 0.13 | −0.007 ± 0.028 | −0.0095 ± 0.017 | – |
Pg | −0.075 ± 0.15 | 0.076 ± 0.035* | – | 0.017 ± 0.026 | |
Supragingival | Aa | 0.066 ± 0.10 | −0.029 ± 0.027 | −0.017 ± 0.015 | – |
Pg | −0.084 ± 0.15 | 0.062 ± 0.033 | – | 0.030 ± 0.027 | |
Subgingival | Aa | −0.17 ± 0.12 | −0.035 ± 0.029 | −0.0049 ± 0.017 | – |
Pg | −0.18 ± 0.15 | 0.071 ± 0.034* | – | 0.014 ± 0.026 |
CRP, C-reactive protein; LPS, lipopolysaccharide; Aa, Aggregatibacter actinomycetemcomitans; Pg, Porphyromonas gingivalis.
Significant *(p < 0.05).
All periodonpathogens amounts expressed in log10 of number of genome equivalents (Geq/ml).
Log-transform applied to antibodies concentration, CRP and LPS.
Regression coefficients derived by linear regression adjusted for group (stable/unstable); a positive (negative) coefficient indicates an increasing (decreasing) relationship between pathogens and CRP, LPS and antibodies amount.